GSK plc
GLAXF
$26.00
$0.532.08%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 95.60% | 131.02% | 128.01% | -13.09% | -29.53% |
| Total Depreciation and Amortization | -30.40% | -8.34% | 17.65% | 47.97% | 32.62% |
| Total Amortization of Deferred Charges | 8.28% | 8.28% | 7.16% | 7.16% | 7.16% |
| Total Other Non-Cash Items | 126.34% | 45.76% | 713.52% | 94,278.20% | 90,129.49% |
| Change in Net Operating Assets | -1,229.85% | -758.54% | -216.54% | -163.49% | -118.25% |
| Cash from Operations | 19.72% | 22.17% | 8.83% | 6.80% | -10.29% |
| Capital Expenditure | -4.55% | 0.20% | -1.41% | -1.18% | -4.15% |
| Sale of Property, Plant, and Equipment | -20.18% | -61.58% | 573.08% | 230.74% | 200.96% |
| Cash Acquisitions | -170.06% | -113.48% | -134.05% | -6.20% | 58.53% |
| Divestitures | 1,517.96% | -56.85% | -73.25% | -105.22% | -131.34% |
| Other Investing Activities | -3,874.62% | -233.00% | -165.01% | -159.13% | -101.46% |
| Cash from Investing | -113.00% | -248.40% | -3,618.95% | -1,043.99% | -69.43% |
| Total Debt Issued | -32.15% | 138.18% | 382.68% | 300.74% | 1,138.91% |
| Total Debt Repaid | 30.48% | 29.42% | -0.43% | -23.56% | 13.76% |
| Issuance of Common Stock | -21.43% | -25.00% | -33.33% | -25.00% | -36.36% |
| Repurchase of Common Stock | -489.47% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.10% | -8.32% | -8.63% | -8.80% | -11.71% |
| Other Financing Activities | 18.38% | -12.53% | -44.70% | -7.66% | -11.83% |
| Cash from Financing | -58.48% | 17.15% | 47.55% | 52.37% | 54.87% |
| Foreign Exchange rate Adjustments | 88.08% | 66.09% | 133.10% | -77.31% | 45.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -169.78% | -148.12% | -2,699.00% | 352.82% | 1,343.70% |